The metzincin metalloproteinase pregnancy-associated plasma protein-A (PAPP-A, pappalysin-1) promotes cell growth by proteolytic cleavage of insulin-like growth factorbinding proteins 4 and 5, causing the release of bound insulin-like growth factors. PAPP-A binds an unknown cell-surface heparan sulfate proteoglycan, suggesting that it controls insulin-like growth factor signaling spatially. In human pregnancy, the majority of PAPP-A circulates as a disulfidebonded complex with its inhibitor, the proform of eosinophil major basic protein (proMBP). Interestingly, Ser-62 of proMBP is substituted with a glycosaminoglycan (GAG) chain, possibly a heparan sulfate type, and the PAPPA⅐proMBP complex is unable to bind to the cell surface. We show here that proMBP detaches surface-bound PAPP-A in a process that depends on the proMBP GAG and also on the formation of intermolecular disulfide bonds between PAPP-A and proMBP. Unlike what was expected, we demonstrate that the GAG of proMBP is not required for PAPPA⅐proMBP complex formation and that proMBP residues His-137, Ser-178, Arg-179, and Asn-181 are important for the recognition of PAPP-A. Using a mouse model, we find that the half-life of circulating PAPP-A and proMBP in complex is severalfold higher than both of the uncomplexed proteins, further suggesting that the PAPP-A⅐proMBP complex is formed at the cell surface in vivo rather than in the circulation. Further supporting this, we show that formation of the PAPP-A⅐proMBP complex at the cell surface proceeds rapidly compared with the slow rate of complex formation in solution. Because both PAPP-A and proMBP are expressed ubiquitously, this model may be applicable to many tissues in which insulin-like growth factor bioavailability is locally regulated.
The metzincin metalloproteinase pregnancy-associated plasma protein-A (PAPP-A, 2 pappalysin-1) cleaves insulin-like growth factor-binding proteins 4 and 5 (1, 2) , which generally function to antagonize the activity of insulin-like growth factors (IGF)-I and -II. The cleavage of insulin-like growth factorbinding protein in complex with IGF results in the release of bioactive IGF, and the responsible proteinase is consequently an important modulator of IGF activity (3) . Accordingly, the proteolytic activity of PAPP-A is believed to be involved in a number of physiological and pathological processes known to involve IGF signaling, e.g. ovarian follicular development (4), human implantation (5) , fetal development (6 -8) , wound healing (9) , and atherosclerosis (10) .
The binding of PAPP-A to an unknown heparan sulfate proteoglycan directs its proteolytic activity to the surface of cells (11) , suggesting that surface binding controls PAPP-A-mediated IGF release and consequently IGF signaling spatially. Mapping experiments localized the site responsible for specific surface binding to complement control protein (CCP) modules 3 and 4 in the C-terminal region of PAPP-A, which contains five consecutive CCP modules (11, 12) . These modules, originally known from proteins associated with the complement system, are responsible for interactions with glycosaminoglycans (GAGs) in several other proteins (13, 14) .
The proteolytic activity of PAPP-A is inhibited physiologically by the proform of eosinophil major basic protein (proMBP) (15) that also binds to a cell surface heparan sulfate proteoglycan (16) . The inhibitory activity of proMBP requires the formation of a disulfide-mediated covalent proteinase-inhibitor complex, denoted PAPP-A⅐proMBP, a 2:2 heterotetramer of 500 kDa held together by 7 intermolecular disulfide bonds (15, 17, 18) . Complex formation between PAPP-A and proMBP is a relatively slow process in vitro but is accelerated severalfold by micromolar concentrations of reductant (17) . The PAPP-A⅐proMBP complex was first discovered in the cir-culation of pregnant women (19) where its origin is the placenta (20) , but both PAPP-A and proMBP are ubiquitously expressed at lower levels (21) . Other known covalent proteinase-inhibitor complexes, e.g. complexes of serpins or ␣2-macroglobulin with their target proteinases, are rapidly cleared from circulation (22, 23) . However, it is unknown whether complex formation with proMBP mediates the clearance of PAPP-A.
ProMBP is substituted with a single GAG chain, possibly of the heparan sulfate type, covalently bound to Ser-62 3 (24) . Such covalent modification of soluble proteins is unusual and restricted to a distinct set of proteoglycans, e.g. bikunin, a component of inter-␣-trypsin inhibitor, which is substituted with a chondroitin sulfate GAG that functions to bind the additional subunits (25) . The function of the proMBP GAG is unknown, but the PAPP-A⅐proMBP complex does not exhibit cell surface binding, and surface binding can be regained after the treatment of the PAPP-A⅐proMBP complex with heparinase (11) .
In this study we demonstrate that proMBP detaches PAPP-A from the cell surface in a process that depends on GAG covalently bound to proMBP and requires the formation of intermolecular PAPP-A⅐proMBP disulfide bonds. Unlike what was expected, the recognition between PAPP-A and proMBP is not mediated by protein-GAG interactions. Rather, we identify proMBP residues His-137, Ser-178, Arg-179, and Asn-181 as part of a site responsible for the recognition of PAPP-A. The PAPP-A⅐proMBP complex is formed rapidly at the cell surface compared with the slow rate of complex formation in solution, indicating that the redox potential of the tissue microenvironment controls the process. Using a mouse model, we find that the half-life of the PAPP-A⅐proMBP complex is severalfold higher than the uncomplexed components. This further supports that the circulating PAPP-A⅐proMBP complex in human pregnancy is formed at the surface of cells within the placenta rather than in the circulation.
EXPERIMENTAL PROCEDURES
Mutagenesis-Site-directed mutagenesis of proMBP cDNA was carried out by overlap extension PCR (26) using proMBP cDNA contained in pcDNA3.1ϩ (pcDNA3.1-proMBP (15)) as the template. Outer primers derived from pcDNA3.1ϩ were 5Ј-CCCCA-TTGACGCAAATGGGCGG-3Ј (5Ј end) and 5Ј-AGGAAAGGA-CAGTGGGAGTGG-3Ј (3Ј end). Internal primers with an overlap of ϳ22 bp were used to generate mutated fragments that were digested with NheI/XhoI and swapped into the wild-type construct. PCRs were carried out with Pfu DNA polymerase (Promega), and all constructs were verified by sequence analysis. Plasmid DNA for transfection was prepared using the QIAprep Spin kit (Qiagen). At least two independent clones of each construct were used for further analysis.
Cell Culture and Transfection-Human embryonic kidney 293T cells (293tsA1609neo) (27) were maintained in high glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM glutamine, nonessential amino acids, and gentamicin (Invitrogen). Cells (4.5 ϫ 10 6 ) were plated onto 6-cm culture dishes and transfected 18 h later by calcium phosphate co-precipitation (28) using 10 g of plasmid DNA. The cells were transfected with either a proMBP or a PAPP-A expression vector, and the medium was harvested 48 h post-transfection. In different experiments cells transfected with PAPP-A cDNA or co-transfected with both PAPP-A and proMBP cDNAs were detached with phosphate-buffered saline (PBS) containing 5 mM EDTA 48 h post-transfection and analyzed by flow cytometry. All proMBP mutants expressed at a level of 10 -20 g/ml, similar to the level of wild-type proMBP, as determined by enzyme-linked immunosorbent assay (ELISA) (see below).
In Vitro Formation of the PAPP-A⅐ProMBP Complex-PAPPA⅐proMBP complex formation experiments were performed as described (15) . In brief, culture medium from 293T cells transfected separately with PAPP-A or proMBP cDNAs were mixed to final concentrations of 20 nM PAPP-A and 200 nM proMBP. The proteins were incubated at 37°C, and samples were taken out and frozen at defined time points between 0 and 48 h. Complex formation was quantitatively monitored by an ELISA specific for the complex (see below). The effect of GAGs on PAPPA⅐proMBP complex formation was studied by the addition of 0 or 100 g/ml heparan sulfate (16,500 g/mol), chondroitin sulfate (14,900 g/mol), or dermatan sulfate (17,800 g/mol) (gifts of Kristian Johansen, LEO Pharma) to the reaction mixtures. Increasing concentrations of NaCl were also added to the mixture to study the effect of increasing ionic strength on PAPPA⅐proMBP complex formation. PAPP-A⅐proMBP complex formation was also studied using purified PAPP-A (variant E483A (29) ) and proMBP diluted to final concentrations of 20 and 200 nM, respectively, in 50 mM Tris, 100 mM NaCl, 100 M CaCl 2 , pH 7.4. PAPP-A and proMBP were purified by immunoaffinity chromatography using a PAPP-A specific (mAb 234-5 (30)) or a proMBP specific (mAb 234-10 (30)) monoclonal antibody immobilized to CNBr-activated Sepharose 4B (GE Healthcare). Complex formation at the surface of cells was analyzed in 96-well culture plates (Nunc) with ϳ60,000 cells/well. After 24 h, the culture medium was replaced with conditioned medium from cells expressing PAPP-A and incubated for 1 h on ice. The cells were washed 3 times with culture medium and subsequently incubated at 37°C with conditioned medium from cells expressing proMBP or proMBP variants. Samples of culture medium were frozen at defined time points (0 -16 h) and subjected to the complex-specific ELISA. The cells of each well were detached with 50 l of PBS supplemented with 5 mM EDTA and 1 M NaCl to measure surface-bound PAPP-A by ELISA. In other experiments complex formation was monitored using 20 nM PAPP-A and 100 nM proMBP without preincubation on ice and without washing the cells.
ELISA-The concentrations of PAPP-A and proMBP were measured by sandwich ELISAs in 96-well microtiter plates (Nunc) using polyclonal rabbit anti-(PAPP-A⅐proMBP) (31) for capture. Monoclonal antibodies against PAPP-A (PA-1A) or proMBP (PM-5A) 4 followed by peroxidase-conjugated anti-(mouse IgG) (P0260, DAKO) were used for detection. The wells were blocked by incubation with PBS containing 2% bovine serum albumin. Antibodies were diluted in PBS containing 0.01% Tween 20 (PBST) and 1% bovine serum albumin. PBST was used for washing. To assure that the binding of monoclonal antibody PM-5A to the proMBP mutants was not altered as a result of the amino acid substitutions, the expression levels of proMBP mutants were also verified by ELISA using rabbit anti-(PAPP-A⅐proMBP) polyclonal antibody for capture and biotinylated rabbit anti-(PAPP-A⅐proMBP) followed by incubation with peroxidase-conjugated avidin (P0347, DAKO) for detection. The amount of PAPP-A⅐proMBP complex formed under different conditions was specifically measured as described (15) . In brief, a PAPP-A-specific monoclonal antibody (PA-1A) was used as the catching antibody, and the PAPP-A⅐proMBP complex was detected with a biotinylated, proMBP-specific monoclonal antibody (PM-5A) followed by incubation with peroxidase-conjugated avidin. In this assay, sample dilution and washing after sample incubation were carried out using PBS containing 0.01% Tween 20 supplemented with 800 mM NaCl to avoid non-covalent association. A dilution series of the PAPPA⅐proMBP complex purified from pregnancy serum (31) was used to establish standard curves.
Western Blotting-Western blotting of wild-type proMBP and proMBP(S62A) was performed after separation by SDS-PAGE (10 -20% Tris-glycine gels). After electrophoresis, proteins were blotted onto a polyvinylidene difluoride membrane and blocked in 2% skimmed-milk powder diluted in 50 mM Tris, 500 mM sodium chloride, 0.1% Tween 20, pH 9.0 (TST). After washing and equilibration in TST, the membrane was incubated with a PAPP-A-specific monoclonal (mAb 234-5) or polyclonal rabbit anti-(PAPP-A⅐proMBP), diluted to 1 or 2.5 g/ml, respectively, in TST containing 2% skimmed-milk powder, and incubated for 1 h at room temperature. Incubation with peroxidase-conjugated secondary antibodies (P0217, DAKO) diluted in TST containing 2% skimmed-milk powder was done for 0.5 h at room temperature. The blots were developed using enhanced chemiluminescence (ECL, Amersham Biosciences), and images were captured with an Eastman Kodak Co. Image Station 1000.
Circular Dichroism (CD) Spectroscopy-Wild-type proMBP and selected mutants were purified by immunoaffinity chromatography (see above). The purity of the proteins was assessed by SDS-PAGE, and the purified proteins were dialyzed against 20 mM NaH 2 PO 4 , 20 mM NaF, pH 7.4. Protein concentrations were determined by amino acid analysis (32) . Three CD spectra were recorded at 25°C for each protein on a Jasco J-810 spectropolarimeter. (Jasco Spectroscopic, Japan) using a polypeptide concentration of ϳ0.1 mg/ml and a cuvette of 2-mm path length. CD data were obtained in the range from 260 to 190 nm at a resolution of 1 nm using a bandwidth of 1.0 nm. The scan speed was 100 nm/min, and the response time was 1 s. To assess the stability of the wild-type and mutant proteins, temperature scans from 30 to 90°C at intervals of 10°C in the range from 240 to 200 nm were also carried out. ⌬⑀ (expressed in millidegrees ϫ cm Ϫ1 ϫ m
Ϫ1
) were calculated on the basis of a mean molar mass of 110 g/mol/residue.
Flow Cytometry-Transfected cells detached with PBS containing 5 mM EDTA were washed with cold Dulbecco's modified Eagle's medium (Invitrogen) containing 2% fetal bovine serum (Dulbecco's modified Eagle's medium/fetal bovine serum) and incubated on ice for 1 h with a PAPP-A-specific The amount of covalent PAPP-A⅐proMBP complex formed over time was measured using an ELISA specific for the complex that was based on PAPP-A and proMBP monoclonal antibodies (15) . Complex formation is expressed relative to the amount of complex formed after 48 h (100%). The gel inset shows a Western blot of PAPP-A incubated with wild-type proMBP for 0 h (lane 1) or 48 h (lane 2) using a PAPP-A specific monoclonal antibody. B, complex formation by the incubation of PAPP-A with either wild-type proMBP (circles) or proMBP(S62A) (squares) and monitored over time by ELISA. The gel inset shows wild-type proMBP (lane 1) and proMBP(S62A) (lane 2) analyzed by reducing SDS-PAGE followed by Western blotting using polyclonal antibodies. GAG-substituted proMBP migrates as a high molecular weight species, and it is seen that wild-type proMBP is only partially GAG-substituted. In contrast, proMBP(S62A) migrates exclusively as the low molecular weight species not substituted with GAG (16) . Complex formation is expressed relative to the amount of complex formed after 48 h (100%). C, PAPP-A⅐proMBP complex formation using purified PAPP-A and purified wild-type proMBP (filled circles) or purified proMBP(S62A) (filled squares) contained in 50 mM Tris, 100 mM NaCl, 100 M CaCl 2 , pH 7.4. Complex formation is expressed relative to the amount of complex formed after 48 h (100%). D, PAPP-A⅐proMBP complex formation after 48 h in the presence of increasing concentrations of NaCl. Results are the averages of at least three independent experiments. S.D. are indicated.
mAb (234-5) (10 g/ml). After three washes in Dulbecco's modified Eagle's medium/fetal bovine serum, the cells were incubated for 30 min on ice with fluorescein isothiocyanate goat anti-mouse IgG (1:50) (Zymed Laboratories Inc.). After 3 washes, the cells were suspended in PBS and analyzed on a Beckman Coulter Cytomics FC 500 MPL flow cytometer. In other experiments non-transfected cells were detached and incubated (1 h on ice) with culture medium containing PAPP-A (10 g/ml) in the absence or presence of purified proMBP (100 g/ml) before staining.
Clearance of PAPP-A⅐ProMBP, PAPP-A, and ProMBP in Mice-Female inbred mice (C57BL/6Jbom, Taconic Ltd.) ϳ9 -10 weeks old were used. The mice were housed in plastic cages under pathogen-free conditions with a 12-hour light/12-hour dark schedule and fed standard chow (Altromin #1324, Lage, Germany) and water ad libitum. Purified human protein samples (5 g/injection) were diluted in sterile-filtered PBS containing 1% bovine serum albumin. In the case of PAPP-A, a proteolytically inactive PAPP-A mutant, E483Q (29) , was used. Before tail vein injection of the sample, the animals were kept at a high ambient temperature to dilate the veins. A volume of 300 l was slowly injected, and blood samples were collected at different time points (1-1440 min) after the injection. Blood samples (20 -30 l) were drawn from the retroorbital plexus into vials (Microvette CB 300 KE, Sarstedt, Germany), and the serum was subsequently obtained by sample centrifugation at 1000 ϫ g and analyzed by ELISA. At the end of the experiment, animals were killed by cervical dislocation. The time course of clearance was analyzed in 10 mice for each protein (a maximum of five blood samples were drawn from each individual mouse) and averaged. Initial analysis revealed a biphasic clearance curve for PAPP-A⅐proMBP, PAPP-A, and proMBP, indicating that clearance can be analyzed by a two-compartment model described by the equation,
in which C is the percentage of injected protein remaining in circulation at a given time (t), k 1 and k 2 are the kinetic rate constants corresponding to the fast and slow phase, respectively, and C 1 and C 2 are the percentages of administered sample removed during the fast and slow phases of clearance (␣-and ␤-phase), respectively. The values of k 1 , k 2 , C 1 , and C 2 were derived for each clearance curve by fitting C versus t to Equation 1 using Sigmaplot 8.0. The half-lives (t1 ⁄ 2 ) of the ␣-and ␤-phase were defined as ␣-phase t1 ⁄ 2 ϭ 0.693/k 1 and ␤-phase t1 ⁄ 2 ϭ 0.693/k 2 . In a similar experiment 8 female BALB/c mice (Taconic) 7-8 weeks old were used. The animal experiments were approved by the Danish Animal Experiments Inspectorate.
RESULTS
The ProMBP GAG Does Not Mediate Recognition between PAPP-A and ProMBP-In one model formation of the covalent proteinase-inhibitor complex between PAPP-A and proMBP (PAPP-A⅐proMBP) requires an initial interaction between the proMBP GAG chain and CCP-3 and -4 of PAPP-A (11). However, the presence of heparan sulfate GAG (100 g/ml) did not affect the formation of the covalent PAPP-A⅐proMBP complex (Fig. 1A) . Similarly, we found that chondroitin or dermatan sulfate did not have any effect on complex formation (data not shown). In a different experiment the amount of PAPP-A⅐proMBP complex formed over time was similar for wild-type proMBP and proMBP(S62A), in which the single GAG-substituted residue of proMBP, Ser-62, is replaced with alanine (16) (Fig. 1B) . This experiment was also carried out with purified proteins with similar results (Fig. 1C) . Therefore, the recognition between PAPP-A and proMBP in the process of complex formation most likely does not depend on protein-GAG interactions. However, because increasing concentrations of salt inhibited PAPP-A⅐proMBP complex formation (Fig. 1D) , other types of ionic interactions are likely to be important in the process.
Mapping of ProMBP Residues Involved in the Recognition of PAPP-A-
Several basic residues of insulinlike growth factor-binding proteins 4 and 5 are known to be important for PAPP-A substrate recognition (33) . We, therefore, speculated that basic residues of the highly basic MBP domain of proMBP might be involved in the proteinase-inhibitor interaction between PAPP-A and proMBP. Thus, the rate of PAPPA⅐proMBP complex formation for a set of proMBP mutants with all surface-exposed basic residues substituted individually or in pairs of two for alanine was compared with wildtype proMBP (Fig. 2, A and B) . All mutants expressed at levels similar to wild-type proMBP, as measured by ELISA using polyclonal antibodies for capture and a proMBP-specific monoclonal antibody (PM-5A) for detection. The expression levels were verified using biotinylated polyclonal antibodies for detection, suggesting that the epitope of mAb PM-5A was not altered as a result of amino acid substitutions. Of the mutants, only proMBP(R179A) showed reduced complex formation (60%) compared with wild-type proMBP (Fig. 2B) . Arg-179 is in proximity with His-137, Ser-178, and Asn-181 in the crystal structure of the MBP domain (34) (Fig. 2, A  and C) . Accordingly, when these three residues were substituted individually by alanine, the ability to form the PAPP-A⅐proMBP complex was reduced by 50 -60% (Fig. 2B) . These mutants and wild-type proMBP migrated similarly in nonreducing SDS-PAGE (Fig. 3A) , and all showed similar CD spectra (Fig.  3B ). In addition, temperature scans were performed from 30 to 90°C in the range from 240 to 200 nm for both wild-type proMBP (Fig. 3C ) and the proMBP mutants (data not shown). The wild-type and mutant proteins all showed similar gradual loss of secondary structure with increasing temperature, measured at 208 nm (Fig. 3D) , further suggesting that the substitutions did not affect the stability of proMBP. In addition, all (24) . Except for the faint band at 60 kDa, the GAG-substituted fraction of proMBP is not visible by Coomassie Blue staining (19) . B, CD spectra of purified wild-type proMBP, proMBP(H137A), proMBP(S178A), proMBP(R179A), and proMBP(N181A) plotted together. The CD spectrum of proMBP(S62A) is also shown. C, temperature scan of 107 g/ml wild-type proMBP from 30 to 90°C at intervals of 10°C in the range of 240 to 200 nm expressed in ellipticity (millidegrees). D, the change in per residue molar absorption (millidegrees ϫ M Ϫ1 ϫ cm proteins were refolded after cooling from 90°C, as the temperature scanning experiments could be largely reproduced for all proteins (data not shown). Therefore, the recognition of PAPP-A by proMBP is based on protein-protein interactions, and residues His-137, Ser-178, Arg-179, and Asn-181 are part of a PAPP-A recognition site of proMBP.
Abrogation of PAPP-A Surface Binding Requires the ProMBP GAG-
Heparan sulfate GAG has previously been reported to abrogate PAPP-A surface binding to an unknown heparan sulfate proteoglycan (11) . We used flow cytometry to analyze to ability of PAPP-A to interact with this molecule. In agreement with the inhibitory effect of GAG, only a small amount of surface-bound PAPP-A was detected in flow cytometry of cells co-transfected with PAPP-A and wild-type proMBP cDNAs compared with cells transfected with PAPP-A cDNA alone (Fig. 4, A and B) . No reduction in PAPP-A surface binding was observed in a similar experiment in which cells were co-transfected with cDNAs encoding PAPP-A and proMBP(S62A) (Fig.  4C ). This suggests that the proMBP GAG is required for proMBP to prevent PAPP-A surface binding.
Covalent PAPP-A⅐ProMBP Complex Formation Is Required for Surface Detachment of PAPP-A-We
speculated that the proMBP GAG might compete with the PAPP-A receptor for binding to CCP-3 and -4. However, under conditions (1 h on ice) where no covalent PAPPA⅐proMBP complex was formed, PAPP-A surface binding was not reduced by the presence of proMBP, as demonstrated using cells incubated with PAPP-A in the absence (Fig. 5A) or presence of excess wild-type proMBP (Fig. 5B) or proMBP(S62A) (Fig. 5C) . We consequently tested if surface-bound PAPP-A can be detached by proMBP under conditions (0 -16 h at 37°C) that allow covalent complex formation using cells incubated first with PAPP-A and subsequently with wild-type proMBP, proMBP(S62A), or a proMBP mutant, proMBP(C51S/C169S) (15), unable to bind covalently to PAPP-A. For cells incubated with wild-type proMBP, the amount of remaining surface-bound PAPP-A was detected over time by ELISA (Fig. 6A) . In contrast, no decrease in surface-bound PAPP-A was detected for cells incubated with proMBP(S62A) or proMBP(C51S/C169S) (Fig. 6A) . Accordingly, an increasing amount of the PAPPA⅐proMBP complex was found in the culture medium of cells (shaded cell populations) . B, a similar experiment with cells incubated with PAPP-A (10 g/ml) and a 50-fold molar excess of wild-type proMBP (100 g/ml). C, a similar experiment with cells incubated with PAPP-A (10 g/ml) and a 50-fold molar excess of proMBP(S62A) (100 g/ml). The cell populations not incubated with PAPP-A are non-shaded. The above results are representative of at least three independent experiments. FIGURE 6. Surface detachment of PAPP-A by proMBP requires covalent complex formation. A, time course of PAPP-A cell surface detachment by proMBP. Cells were plated onto 96-well culture plates at 37°C (ϳ60,000 cells/well). After 24 h, the cells were incubated for 1 h on ice with conditioned medium from cells transfected with PAPP-A cDNA. After 3 washes, the cells were incubated at 37°C with conditioned medium from cells transfected with cDNAs encoding wild-type proMBP (filled circles), proMBP(S62A) (filled squares), or proMBP(C51S/C169S) (filled triangles) or medium from cells transfected with an empty vector (open circles). The cells were detached at defined time points from 0 to 16 h. For increased sensitivity, the amount of remaining surface-bound PAPP-A was measured by ELISA rather than flow cytometry. B, in the same experiment the culture medium was sampled, and the amount of detached PAPP-A⅐proMBP complex was determined using the complex-specific ELISA. Filled circles symbolize wild-type PAPP-A⅐proMBP complex, filled squares symbolize mutant PAPP-A⅐proMBP(S62A) complex, and filled triangles symbolize mutant PAPP-A⅐proMBP(C51S/C169S) complex. C, surface-bound PAPP-A⅐proMBP after 1 h was measured in the cell fraction using ELISA (columns). D, a similar experiment of complex formation carried out in the absence or presence of cells without preincubation on ice and without washing of the cells. Results are averages of four independent experiments. S.D. are indicated.
incubated with wild-type proMBP, whereas only a small increase in the amount of complex was detected for cells incubated with either proMBP(S62A) or proMBP(C51S/C169S) (Fig. 6B) . This conclusively demonstrates that 1) surface-bound PAPP-A is targeted and detached by proMBP, 2) the cell surface detachment of PAPP-A is mediated by the proMBP GAG, and 3) detachment requires the formation of intermolecular PAPPA⅐proMBP disulfide bonds. In addition, the amount of PAPPA⅐proMBP complex detected at the cell surface after 1 h of incubation was significantly higher for cells incubated with proMBP(S62A) than for cells incubated with wild-type proMBP (Fig. 6C) , further suggesting that the covalent PAPPA⅐proMBP complex is formed while the components are bound to the surface. Accordingly, the rate of PAPP-A⅐proMBP complex formation in the presence of cells was accelerated severalfold compared with formation of the complex under cell-free conditions (Fig. 6D) . Thus, surface binding may serve to increase the effective concentrations of PAPP-A and proMBP and, hence, the rate of complex formation.
Rapid Clearance of Uncomplexed PAPP-A and ProMBP in Mice-Other known covalent proteinase-inhibitor complexes are rapidly removed from the circulation (22, 23) . Using female C57BL/6Jbom mice as a model, we found that uncomplexed PAPP-A and proMBP disappeared from the circulation with half-lives in the fast phase (␣-phase t1 ⁄ 2 ) of 0.670 and 2.49 min, respectively ( Fig. 7A and Table 1 ). The vast majority of both PAPP-A (97.2%) and proMBP (88.1%) was cleared in the fast phase, and the half-lives of PAPP-A and proMBP in the slow phase (␤-phase t1 ⁄ 2 ) were 27.9 and 98.5 min, respectively. In striking contrast, the PAPP-A⅐proMBP complex disappeared only slowly from the circulation with an ␣-phase t1 ⁄ 2 of 34.8 min and a ␤-phase t1 ⁄ 2 of 1.48ϫ 10 3 min (Fig. 7B and Table 1 ). Furthermore, the amount of PAPP-A⅐proMBP cleared in the two phases was more equally distributed, with only 62.0% clearing in the ␣-phase. Similar results were obtained in eight female BALB/c mice. In these mice PAPP-A and proMBP cleared with half-lives of ϳ1 and 2-3 min, respectively, whereas the majority of the PAPP-A⅐proMBP complex was still found in the circulation after 30 min when the experiment was terminated.
These results demonstrate that the PAPP-A⅐proMBP complex formation does not promote clearance of PAPP-A. The rapid clearance of the uncomplexed components further suggests that the circulating PAPP-A⅐proMBP complex is formed at the surface of cells, not after secretion into the circulation of uncomplexed PAPP-A and proMBP.
DISCUSSION
In the present study we demonstrate that proMBP abrogates PAPP-A surface binding and that this requires proMBP to be substituted with GAG at Ser-62 (Fig. 4) . Unlike expected, we find that the proMBP GAG does not mediate the recognition of PAPP-A (Fig. 1) . This is in contrast to the formation of another covalent proteinase-inhibitor pair, thrombin-antithrombin-III, which critically depends on the binding of heparin-like glycosaminoglycans, serving as a template on which proteinase and inhibitor can interact (35, 36) . Using site-directed mutagenesis, we further show that the recognition of PAPP-A by proMBP is based on protein-protein interactions rather than protein- The percentages of the administered sample cleared in the fast (C 1 ) and the slow (C 2 ) phase, and the values of the kinetic rate constants (k 1 and k 2 ) of each phase were determined by fitting the clearance data to Equation 1 (see "Experimental Procedures"). The half-lives of the fast phase (␣-phase t1 ⁄ 2 ) and the slow phase (␤-phase t1 ⁄ 2 ) were defined as ␣-phase t1 ⁄ 2 ϭ 0.693/k 1 and ␤-phase t1 ⁄ 2 ϭ 0.693/k 2 , respectively. S.E. are shown in parentheses. GAG interactions and identify proMBP residues His-137, Ser-178, Arg-179, and Asn-181 as part of a site responsible for the recognition of PAPP-A. These residues are located in the extended L2 loop and in the loop between S2 and H2 close to one another in the crystal structure of the MBP domain (Fig. 2 , A and C) (34) . The MBP domain of proMBP belongs to the C-type lectin super family (34) . Known ligands of this family include both carbohydrates and proteins, and the ligand binding region in C-type lectins is usually formed by three extended loops and a ␤-strand, corresponding to L1, L3, L4, and S7 (34) (Fig. 2A) . However, both the PAPP-A recognition site and the recently identified cell surface binding site (16) are located on the opposite side of the MBP domain compared with the C-type lectin ligand binding region (Fig. 2C) , suggesting that proMBP is not a typical C-type lectin. Heparan sulfate GAGs compete with the PAPP-A receptor for PAPP-A surface binding (11) . However, we find that under experimental conditions where no covalent complex is formed, excess proMBP did not affect PAPP-A surface binding (Fig. 5) . Conversely, under conditions that allowed covalent complex formation, surface-bound PAPP-A was rapidly targeted and detached by wild-type proMBP. In contrast, proMBP mutants proMBP(S62A) and proMBP(C51S/ C169S) were unable to detach PAPP-A from the surface (Fig. 6, A  and B) , demonstrating that both GAG substitution at Ser-62 of proMBP and the formation of intermolecular PAPP-A⅐proMBP disulfide bonds are required for detachment of surface-bound PAPP-A.
The covalent PAPP-A⅐proMBP complex is formed at the cell surface (Fig. 6C) . As a result, the proMBP GAG may be localized in close proximity to CCP-3 and -4, allowing it to effectively compete with the PAPP-A receptor, which in turn results in surface detachment of PAPP-A. Interestingly, the rate of PAPP-A⅐proMBP complex formation at the cell surface was accelerated severalfold compared with formation of the complex in the absence of cells (Fig. 6) , suggesting that surface binding may serve to increase the effective concentrations of PAPP-A and proMBP. The complex formation is a multistep process of disulfide rearrangements that is influenced by the redox potential (17) , and cell surface-associated factors, such as disulfide isomerases (37) , potentially participate in the process. Consequently, pathological conditions of altered redox potential, e.g. placental hypoxia in preeclampsia, may change the balance between complexed and uncomplexed PAPP-A and, hence, affect IGF signaling.
How does proMBP lose affinity for its surface receptor before release of the PAPP-A⅐proMBP complex from the cell surface? Cys-169 is located in the loop recently identified as part of the proMBP surface binding site (16) (Fig. 2C) . However, upon complex formation Cys-169 switches from participating in an intramolecular proMBP disulfide bond to the formation of the first intermolecular PAPP-A⅐proMBP disulfide bond with Cys-652 in PAPP-A (17) . We speculate that this causes a conformational change of the loop resulting in the abrogation of proMBP surface binding.
The disulfide rearrangements upon formation of the PAPPA⅐proMBP complex were recently delineated (17) . Based on these and our present findings, we depict a model of how surface-bound PAPP-A is targeted and detached by proMBP (Fig.  8 ). In this model, proMBP binds a cell surface heparan sulfate proteoglycan and recognizes the surface-bound PAPP-A dimer by non-covalent protein-protein interactions. The initial recognition is followed by the formation of intermolecular PAPP- (17) . Covalent complex formation allows the proMBP GAG to compete with the PAPP-A receptor for PAPP-A surface binding, leading to detachment of the PAPP-A⅐proMBP complex (4) . Importantly, the formation of intermolecular disulfide bonds between PAPP-A and proMBP results in the inhibition of PAPP-A proteolytic activity (15) , and therefore, the release of bound IGF cannot occur. Only one of the two subunits of the dimeric PAPP-A is shown. SOS and SH symbolize disulfide bonds and free sulfhydryls, respectively. Further details are given under "Discussion."
